• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Retrospective survey of urea cycle disorders: Part 1. Clinical and laboratory observations of thirty-two Japanese male patients with ornithine transcarbamylase deficiency.

作者信息

Matsuda I, Nagata N, Matsuura T, Oyanagi K, Tada K, Narisawa K, Kitagawa T, Sakiyama T, Yamashita F, Yoshino M

机构信息

Department of Pediatrics, Kumamoto University Medical School Japan.

出版信息

Am J Med Genet. 1991 Jan;38(1):85-9. doi: 10.1002/ajmg.1320380119.

DOI:10.1002/ajmg.1320380119
PMID:2012137
Abstract

In a retrospective survey done from 1978-1988 in Japan, 32 male patients with ornithine transcarbamylase (OTC) deficiency were identified. We classified a neonatal and 2 late-onset groups, depending on clinical manifestations and the age at onset; group 1 (0-28 days; N = 10), group 2 (29 days-5 years; N = 13), and group 3 (greater than 5 years; N = 9). Compared to findings in the group 2 patients, there was a higher rate of mortality and a higher incidence of mental retardation in association with a great decrease in enzyme activity in group 1. In group 3, the mortality rate and enzyme activities were similar to those in group 1. However, patients in this group were asymptomatic prior to the first episode. Enzyme activities were measured mostly in autopsy samples. The serum citrulline levels (enzyme product) were highest in this group. Thus, the mutant enzymes were apparently labile with greater activities in vivo than in vitro. Treatments, including a protein-restricted diet, arginine supplementation, and sodium benzoate administration, resulted in a favorable prognosis for survivors with partial enzyme deficiency. We wish to emphasize that the incidence of late onset of this disease is higher than heretofore considered.

摘要

相似文献

1
Retrospective survey of urea cycle disorders: Part 1. Clinical and laboratory observations of thirty-two Japanese male patients with ornithine transcarbamylase deficiency.
Am J Med Genet. 1991 Jan;38(1):85-9. doi: 10.1002/ajmg.1320380119.
2
The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.鸟氨酸转氨甲酰酶(OTC)基因:50个日本鸟氨酸转氨甲酰酶缺乏症家庭中的突变情况
Am J Med Genet. 1997 Sep 5;71(4):378-83.
3
Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.先天性尿素循环酶缺陷中内源性一氧化氮合成的评估
Metabolism. 2009 Mar;58(3):278-82. doi: 10.1016/j.metabol.2008.09.025.
4
Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.对五名日本鸟氨酸转氨甲酰酶(OTC)缺乏症患者的OTC基因进行突变分析,发现了两个已知突变和三个新突变,其中包括一个内含子深处的突变。
Kobe J Med Sci. 2007;53(5):229-40.
5
Urea cycle disorders in Thai infants: a report of 5 cases.泰国婴儿的尿素循环障碍:5例报告
J Med Assoc Thai. 2002 Aug;85 Suppl 2:S720-31.
6
Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency.新生儿期起病的尿素循环障碍婴儿及迟发性鸟氨酸转氨甲酰酶缺乏症女性患者早期原位肝移植的发育结局
Pediatrics. 2004 Oct;114(4):e523-6. doi: 10.1542/peds.2004-0198.
7
Fatal initial adult-onset presentation of urea cycle defect.尿素循环缺陷的致命性成人首发表现。
Arch Neurol. 2007 Dec;64(12):1777-9. doi: 10.1001/archneur.64.12.1777.
8
Nitric oxide synthesis in ornithine transcarbamylase deficiency: possible involvement of low no synthesis in clinical manifestations of urea cycle defect.
J Pediatr. 2004 Aug;145(2):259-62. doi: 10.1016/j.jpeds.2004.05.033.
9
Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family.由A208T突变引起的无症状和迟发性鸟氨酸转氨甲酰酶缺乏症:一个四代家族的临床、生化和DNA分析
Am J Med Genet. 1997 Jan 20;68(2):236-9.
10
Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency.通过液相色谱-串联质谱法进行的扩大新生儿筛查中的低瓜氨酸血症并非鸟氨酸转氨甲酰酶缺乏症的可靠标志物。
J Pharm Biomed Anal. 2009 Jul 12;49(5):1292-5. doi: 10.1016/j.jpba.2009.03.001. Epub 2009 Mar 20.

引用本文的文献

1
Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys.一种工程化嗜肝腺相关病毒基因疗法治疗食蟹猴鸟氨酸转氨甲酰酶缺乏症的安全性和有效性
Mol Ther Methods Clin Dev. 2021 Sep 14;23:135-146. doi: 10.1016/j.omtm.2021.09.005. eCollection 2021 Dec 10.
2
Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.人源化肝脏小鼠模型,移植了来自鸟氨酸转氨甲酰酶缺乏症患者的人肝细胞。
J Inherit Metab Dis. 2021 May;44(3):618-628. doi: 10.1002/jimd.12347. Epub 2020 Dec 30.
3
Clinical manifestations and growth of patients with urea cycle disorders in Japan.
日本尿素循环障碍患者的临床表现与生长情况
J Hum Genet. 2016 Jul;61(7):613-6. doi: 10.1038/jhg.2016.17. Epub 2016 Mar 3.
4
Acute treatment of hyperammonemia by continuous renal replacement therapy in a newborn patient with ornithine transcarbamylase deficiency.采用持续肾脏替代疗法对一名患有鸟氨酸转氨甲酰酶缺乏症的新生儿患者进行高氨血症的急性治疗。
Korean J Pediatr. 2011 Oct;54(10):425-8. doi: 10.3345/kjp.2011.54.10.425. Epub 2011 Oct 31.
5
Long-term outcome and intervention of urea cycle disorders in Japan.日本尿素循环障碍的长期预后和干预措施。
J Inherit Metab Dis. 2012 Sep;35(5):777-85. doi: 10.1007/s10545-011-9427-0. Epub 2011 Dec 14.
6
Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan.日本尿素循环障碍长期治疗的神经发育结局
J Inherit Metab Dis. 1998;21 Suppl 1:151-9. doi: 10.1023/a:1005374027693.
7
Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency.开发用于鸟氨酸转氨甲酰酶缺乏症的腺病毒介导的体内基因疗法。
J Inherit Metab Dis. 1998;21 Suppl 1:119-37. doi: 10.1023/a:1005369926784.
8
In vivo measurement of ureagenesis with stable isotopes.用稳定同位素进行体内尿素生成的测量。
J Inherit Metab Dis. 1998;21 Suppl 1:21-9. doi: 10.1023/a:1005345205403.
9
In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症中的体内氮代谢
J Clin Invest. 1996 Nov 1;98(9):2167-73. doi: 10.1172/JCI119023.
10
Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.患者选择可能会影响基因治疗的成功率。在小鼠和人类肝细胞中观察到鸟氨酸转氨甲酰酶的显性负效应。
J Clin Invest. 1996 Feb 1;97(3):826-32. doi: 10.1172/JCI118482.